EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 208 filers reported holding EXELIXIS INC in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $364,000 | -19.5% | 20,000 | 0.0% | 0.06% | -26.0% |
| Q1 2021 | $452,000 | +12.7% | 20,000 | 0.0% | 0.08% | +11.6% |
| Q4 2020 | $401,000 | -18.0% | 20,000 | 0.0% | 0.07% | -31.0% |
| Q3 2020 | $489,000 | +2.7% | 20,000 | 0.0% | 0.10% | -2.0% |
| Q2 2020 | $476,000 | +34.8% | 20,000 | 0.0% | 0.10% | +13.3% |
| Q1 2020 | $353,000 | +0.3% | 20,000 | 0.0% | 0.09% | +7.1% |
| Q4 2019 | $352,000 | -0.6% | 20,000 | 0.0% | 0.08% | -16.0% |
| Q3 2019 | $354,000 | -17.1% | 20,000 | 0.0% | 0.10% | -12.3% |
| Q2 2019 | $427,000 | -14.6% | 20,000 | -4.7% | 0.11% | -3.4% |
| Q1 2019 | $500,000 | +25.3% | 20,986 | +4.9% | 0.12% | +55.3% |
| Q4 2018 | $399,000 | +12.7% | 20,000 | 0.0% | 0.08% | +33.3% |
| Q3 2018 | $354,000 | -17.7% | 20,000 | 0.0% | 0.06% | -24.0% |
| Q2 2018 | $430,000 | -2.9% | 20,000 | 0.0% | 0.08% | -8.5% |
| Q1 2018 | $443,000 | -27.1% | 20,000 | 0.0% | 0.08% | -29.9% |
| Q4 2017 | $608,000 | +25.4% | 20,000 | 0.0% | 0.12% | +11.4% |
| Q3 2017 | $485,000 | -1.6% | 20,000 | 0.0% | 0.10% | -7.1% |
| Q2 2017 | $493,000 | +13.9% | 20,000 | 0.0% | 0.11% | +5.6% |
| Q1 2017 | $433,000 | +45.3% | 20,000 | 0.0% | 0.11% | +32.1% |
| Q4 2016 | $298,000 | +16.4% | 20,000 | 0.0% | 0.08% | +8.0% |
| Q3 2016 | $256,000 | +725.8% | 20,000 | 0.0% | 0.08% | +581.8% |
| Q3 2014 | $31,000 | -8.8% | 20,000 | +100.0% | 0.01% | -8.3% |
| Q2 2014 | $34,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |